Markets:

Overview

News

Currencies

International

Treasuries

Atara Biotherapeutics, Inc. - Common Stock (NQ:ATRA)

4.830 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atara Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 06, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 20, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.

Via Benzinga

Atara Biotherapeutics's Earnings Outlook ↗

August 07, 2023

Via Benzinga

Atara Biotherapeutics Earnings Perspective: Return On Capital Employed ↗

May 23, 2023

Via Benzinga

A Preview Of Atara Biotherapeutics's Earnings ↗

May 05, 2023

Via Benzinga

Looking Into Atara Biotherapeutics's Return On Capital Employed ↗

February 10, 2023

Via Benzinga

Atara Biotherapeutics Announces Plans to Submit Tab-cel® BLA in Q2 2024 Following FDA Agreement on Comparability

September 19, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

September 01, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Participate in Cell Therapies in Autoimmune Panel Discussion at the Citi 18th Annual BioPharma Conference

August 31, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 08, 2023

Via Benzinga

Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress

August 08, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 04, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

August 01, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference

July 31, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

3 Doomed Biotech Stocks Destined for Disaster ↗

July 17, 2023

Doomed biotech stocks are a major part of the natural cycle within the sector that results in a lot of failures.

Via InvestorPlace

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 07, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

June 07, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023

June 05, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 02, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 09, 2023

Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.

Via Benzinga

Atara Biotherapeutics Announces First Quarter 2023 Financial Results and Operational Progress

May 08, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 05, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Announce First Quarter 2023 Financial Results on Monday, May 8, 2023

May 01, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

3 Stocks to Buy That Could Be the Next Biotech Breakthrough ↗

April 16, 2023

Biotech stocks are highly speculative, but it's possible to choose ones with excellent risk-reward ratios.

Via InvestorPlace

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 31, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 03, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 43rd Annual Health Care Conference

March 01, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Participate in the H.C. Wainwright Cell Therapy Virtual Conference

February 21, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 08, 2023

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Atara Biotherapeutics, Inc. - Common Stock (NQ:ATRA)

All News about Atara Biotherapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today